# Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women

> **NCT07429734** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Mansoura University** · enrollment: 60 (estimated)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** solifenacin combined with gabapentin
- **DRUG:** solifenacin monotherapy

## Key facts

- **NCT ID:** NCT07429734
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-10
- **Final completion:** 2027-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429734, "Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07429734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*